首页> 外文期刊>Frontiers in Molecular Biosciences >Hydrogen Sulfide Protects Against Uremic Accelerated Atherosclerosis via nPKCδ/Akt Signal Pathway
【24h】

Hydrogen Sulfide Protects Against Uremic Accelerated Atherosclerosis via nPKCδ/Akt Signal Pathway

机译:硫化氢通过NPKCδ/ AKT信号途径免受尿毒症加速动脉粥样硬化

获取原文
           

摘要

Background: Cardiovascular disease is the most common complication and leading cause of death in maintenance hemodialysis patients. Previous studies have found that disorders of cystathionine-gamma-lyase/hydrogen sulfide (CSE/H2S) system in maintenance hemodialysis patients are correlated with the risk of cardiovascular disease. Although the role of CSE/H2S system in UAAS has been preliminarily explored, the molecular mechanism of CSE/H2S is still not systematically elaborated, and the molecular mechanism of nPKCδ and its related signaling pathway in UAAS is still not thoroughly studied. Methods: Forty chronic kidney disease (CHD) patients were studied and the activation of nPKCδ in peripheral blood mononuclear cells (PBMCs) were detected. ApoE-/- mice aged 6 weeks were treated with 5/6 nephrectomy and high-fat diet to make UAAS model. They were divided into Sham group (Sham group), UAAS group (UAAS group), UAAS L-cysteine group (UAAS L-cys group), UAAS sodium hydrosulfide group (UAAS NaHS group) and UAAS propargylglycine group (UAAS PPG group). The UAAS L-cys group, UAAS NaHS group and UAAS PPG group were respectively given L-cys, NaHS and PPG by intraperitoneal injection. The aorta was taken 6 weeks after surgery. Western blot was used to detect the activation of nPKCδ, the phosphorylation of Akt, and the expression of VCAM-1 in the aorta of mice. Results: The membrane translocation of nPKCδ in CHD patients with plaque was higher than that in CHD patients without plaque. The membrane translocation of nPKCδ and the expression of VCAM-1 in UAAS group was higher than sham group, L-cys or NaHS injection could suppress the membrane translocation of nPKCδ and the expression of VCAM-1, but PPG treatment resulted in more membrane translocation of nPKCδ and the expression of VCAM-1 (P0.05, n=6 per group). Akt phosphorylation in UAAS group was lower than sham group, and L-cys or NaHS injection could suppress the degradation of Akt phosphorylation, but PPG treatment resulted in more decrease in the Akt phosphorylation (P0.05, n=6 per group). Conclusion: Endogenous CSE/H2S system protected against the formation of UAAS via nPKCδ/Akt signal pathway. The imbalance of CSE/H2S system may participate in the formation of UAAS by affecting the expression of downstream molecule VCAM-1, which may be mediated by nPKCδ/Akt signaling pathway.
机译:背景:心血管疾病是维持血液透析患者的最常见的并发症和死亡原因。以前的研究发现,维持血液透析患者中​​的胱硫胺-γ-γ-裂解酶/硫化氢(CSE / H2S)系统的疾病与心血管疾病的风险相关。虽然CSE / H2S系统在UAAs中的作用已经初步探索,但CSE / H2S的分子机制仍未系统地阐述,并且uAA中的NPKCδ及其相关信号通路的分子机制仍未彻底研究。方法:研究了四十慢性肾病(CHD)患者,检测到外周血单核细胞(PBMCs)中NPKCδ的活化。 Apoe - / - 6周龄的小鼠用5/6肾切除术和高脂饮食治疗,以使UAAs模型。它们被分为假组(假手术组),UAAs组(UAAs组),UAAs L-Cyseine组(UAAs L-Cys组),Uaas硫化氢钠组(Uaas NaHS组)和UAAs PPG组)。 UAAS L-Cys组,UAAS NaHS组和UAAs PPG组分别通过腹膜内注射给予L-Cys,NaHs和PPG。手术后6周服用主动脉。用于检测NPKCδ的激活,AKT的磷酸化以及小鼠主动脉中的VCAM-1的表达。结果:斑块CHD患者中NPKCδ的膜易位高于CHD患者,无斑块。 NPKCδ的膜易位和UAAs组中VCAM-1的表达高于假组,L-Cys或NaHS注射可以抑制NPKCδ的膜易位和VCAM-1的表达,但PPG处理导致更多的膜易位NPKCδ和VCAM-1的表达(P <0.05,每组0.05,n = 6)。 UAAs组中的Akt磷酸化低于假手术,L-Cys或NaHS注射可以抑制AKT磷酸化的降解,但是PPG处理导致AKT磷酸化的降低(P <每组P <0.05,n = 6)。结论:内源性CSE / H2S系统免受NPKCδ/ AKT信号通路形成UAAS的影响。通过影响下游分子VCAM-1的表达,CSE / H2S系统的不平衡可以参与UAA的形成,这可以通过NPKCΔ/ AKT信号通路介导的下游分子VCAM-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号